Using ultrasound features to classify liver nodules
Part of Cancer, Digestive system clinical trials.
This trial looks at whether special features seen on contrast-enhanced ultrasound can help doctors better classify liver nodules using a system called LI-RADS. It’s for people at high risk for liver cancer who have recent imaging and clear tissue diagnosis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have liver cirrhosis, chronic hepatitis B, or a history of liver cancer, or you are an adult liver transplant patient.
- You had both a contrast-enhanced ultrasound and a contrast-enhanced CT or MRI within 2 months before surgery.
- You have clear results from a biopsy or from examining the tumor after surgery.
- Your medical records, including imaging and pathology reports, are complete.
- You have not received chemotherapy, immunotherapy, targeted therapy, or local treatments like TACE or ablation for your liver lesions.
- You do not have certain types of contrast enhancement seen on ultrasound that would make LI-RADS unsuitable.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new ultrasound technique to catch liver cancer sooner. If you have regular imaging checks for liver cancer or are getting an MRI for a liver spot, you may be able to join.
This study compares an artificial intelligence tool against a standard liver scan scoring system (LI-RADS) to diagnose liver cancer (HCC) on CT scans. It may help make liver cancer detection more accurate for people at higher risk.
This study uses a special ultrasound with contrast dye to look at liver nodules seen on MRI in people who have had cancer. The goal is to see if the ultrasound can better tell if these nodules are cancerous.
This trial compares two types of imaging scans (CEUS and AMRI) to see which one is better at finding liver cancer (HCC) in patients who have an unclear spot on their liver (an indeterminate nodule). It is for people with cirrhosis who have at least one such nodule but no confirmed liver cancer yet.
This trial tests whether a special ultrasound scan using contrast dye can better detect early liver cancer in people with cirrhosis (scarring of the liver). The goal is to catch liver cancer at an earlier, more treatable stage.
This trial compares two types of scans to see which detects liver cancer better in people at high risk. You would receive either an MRI with contrast or an ultrasound every 6 months to monitor for liver cancer.
Hear when a new Liver Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.